{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:25:12Z","timestamp":1787019912338,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-01982-9","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T04:55:06Z","timestamp":1740545706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Network meta-analysis comparing efficacy of different strategies on medication-overuse headache"],"prefix":"10.1186","volume":"26","author":[{"given":"Prut","family":"Koonalintip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suppakorn","family":"Yamutai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwanna","family":"Setthawatcharawanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therdpong","family":"Thongseiratch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ply","family":"Chichareon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Wakerley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"1982_CR1","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 38(1):1\u2013211","DOI":"10.1177\/0333102417738202"},{"issue":"2","key":"1982_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2042098614522683","volume":"5","author":"ES Kristoffersen","year":"2014","unstructured":"Kristoffersen ES, Lundqvist C (2014) Medication-overuse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf 5(2):87\u201399","journal-title":"Ther Adv Drug Saf"},{"issue":"6","key":"1982_CR3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/0333102413512033","volume":"34","author":"ML Westergaard","year":"2014","unstructured":"Westergaard ML, Hansen EH, Gl\u00fcmer C, Olesen J, Jensen RH (2014) Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review. Cephalalgia 34(6):409\u2013425","journal-title":"Cephalalgia"},{"key":"1982_CR4","doi-asserted-by":"crossref","unstructured":"Steiner TJ, Birbeck GL, Jensen RH, Katsarava Z, Stovner LJ, Martelletti P. (2015) Headache disorders are third cause of disability worldwide. J Headache Pain. 16(1):58:s10194\u2013015\u20130544\u20132","DOI":"10.1186\/s10194-015-0544-2"},{"issue":"6","key":"1982_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jpain.2016.12.005","volume":"18","author":"MJ De Goffau","year":"2017","unstructured":"De Goffau MJ, Klaver ARE, Willemsen MG, Bindels PJE, Verhagen AP (2017) The Effectiveness of Treatments for Patients With Medication Overuse Headache: A Systematic Review and Meta-Analysis. J Pain 18(6):615\u2013627","journal-title":"J Pain"},{"issue":"9","key":"1982_CR6","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/life14091146","volume":"14","author":"P Koonalintip","year":"2024","unstructured":"Koonalintip P, Phillips K, Wakerley BR (2024) Medication-Overuse Headache: Update on Management. Life 14(9):1146","journal-title":"Life"},{"issue":"9","key":"1982_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/jamaneurol.2020.1179","volume":"77","author":"LN Carlsen","year":"2020","unstructured":"Carlsen LN, Munksgaard SB, Nielsen M, Engelstoft IMS, Westergaard ML, Bendtsen L et al (2020) Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial. JAMA Neurol 77(9):1069","journal-title":"JAMA Neurol"},{"issue":"4","key":"1982_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/head.14692","volume":"64","author":"AC Charles","year":"2024","unstructured":"Charles AC, Digre KB, Goadsby PJ, Robbins MS, Hershey A (2024) The American Headache Society. Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update. Headache J Head Face Pain. 64(4):333\u201341","journal-title":"Headache J Head Face Pain."},{"issue":"1","key":"1982_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11916-011-0240-0","volume":"16","author":"JL Fuh","year":"2012","unstructured":"Fuh JL, Wang SJ (2012) Dependent Behavior in Patients with Medication-Overuse Headache. Curr Pain Headache Rep 16(1):73\u201379","journal-title":"Curr Pain Headache Rep"},{"issue":"5","key":"1982_CR10","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/ADM.0000000000000504","volume":"13","author":"C Lundqvist","year":"2019","unstructured":"Lundqvist C, Gossop M, Russell MB, Straand J, Kristoffersen ES (2019) Severity of Analgesic Dependence and Medication-overuse Headache. J Addict Med 13(5):346\u2013353","journal-title":"J Addict Med"},{"issue":"5","key":"1982_CR11","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s13760-021-01758-3","volume":"121","author":"AL Moraes Alves","year":"2021","unstructured":"Moraes Alves AL, Silva IK, Paula Lemos PH, Lomachinsky Torres V, Crevanzi Arraes E, Sampaio Rocha-Filho PA (2021) FRAMES protocol versus simple advice for medication-overuse headache: a prospective, randomized, controlled clinical trial. Acta Neurol Belg 121(5):1259\u20131264","journal-title":"Acta Neurol Belg"},{"issue":"5","key":"1982_CR12","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/ene.15256","volume":"29","author":"JA Pijpers","year":"2022","unstructured":"Pijpers JA, Kies DA, Van Zwet EW, Rosendaal FR, Terwindt GM (2022) Behavioural intervention in medication overuse headache: A concealed double-blind randomized controlled trial. Eur J Neurol 29(5):1496\u20131504","journal-title":"Eur J Neurol"},{"issue":"5","key":"1982_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/jnnp-2014-308548","volume":"86","author":"ES Kristoffersen","year":"2015","unstructured":"Kristoffersen ES, Straand J, Vetvik KG, Benth J\u0160, Russell MB, Lundqvist C (2015) Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial. J Neurol Neurosurg Psychiatry. 86(5):505\u201312","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"1982_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jocn.2018.09.021","volume":"60","author":"A Granato","year":"2019","unstructured":"Granato A, Fantini J, Monti F, Furlanis G, Musho Ilbeh S, Semenic M et al (2019) Dramatic placebo effect of high frequency repetitive TMS in treatment of chronic migraine and medication overuse headache. J Clin Neurosci 60:96\u2013100","journal-title":"J Clin Neurosci"},{"issue":"3;5","key":"1982_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.36076\/ppj.2012\/15\/245","volume":"15","author":"DRG Serra","year":"2012","unstructured":"Serra DRG (2012) Occipital Nerve Stimulation for ChronicMigraine: A Randomized Trial. Pain Physician. 15(3;5):245\u201353","journal-title":"Pain Physician."},{"issue":"1","key":"1982_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.clinph.2020.10.014","volume":"132","author":"R De Icco","year":"2021","unstructured":"De Icco R, Putort\u00ec A, De Paoli I, Ferrara E, Cremascoli R, Terzaghi M et al (2021) Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial. Clin Neurophysiol 132(1):126\u2013136","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"1982_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C et al (2015) The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations. Ann Intern Med 162(11):777\u2013784","journal-title":"Ann Intern Med"},{"key":"1982_CR18","doi-asserted-by":"crossref","unstructured":"Olesen J. (2005) The international classification of headache disorders. 2nd edition (ICHD-II). Rev Neurol (Paris). 161(6\u20137):689\u201391","DOI":"10.1016\/S0035-3787(05)85119-7"},{"key":"1982_CR19","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 33(9):629\u2013808","DOI":"10.1177\/0333102413485658"},{"issue":"1","key":"1982_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5(1):210","journal-title":"Syst Rev"},{"key":"1982_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 28:l4898","journal-title":"BMJ"},{"issue":"1","key":"1982_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT (2021) Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods 12(1):55\u201361","journal-title":"Res Synth Methods"},{"key":"1982_CR23","doi-asserted-by":"crossref","unstructured":"Schwarzer G, Carpenter JR, R\u00fccker G. (2015) Meta-Analysis with R. Cham: Springer. 252 p. (Use R!)","DOI":"10.1007\/978-3-319-21416-0"},{"issue":"11","key":"1982_CR24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"2","key":"1982_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1468-2982.2008.01711.x","volume":"29","author":"K Hagen","year":"2009","unstructured":"Hagen K, Albretsen C, Vilming S, Salvesen R, Gr\u00f8ning M, Helde G et al (2009) Management of Medication Overuse Headache: 1-Year Randomized Multicentre Open-Label Trial. Cephalalgia 29(2):221\u2013232","journal-title":"Cephalalgia"},{"issue":"4","key":"1982_CR26","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/ane.12692","volume":"135","author":"\u00d6 Karada\u015f","year":"2017","unstructured":"Karada\u015f \u00d6, \u00d6z\u00f6n A\u00d6, \u00d6z\u00e7elik F, \u00d6zge A (2017) Greater occipital nerve block in the treatment of triptan-overuse headache: A randomized comparative study. Acta Neurol Scand 135(4):426\u2013433","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"1982_CR27","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/brain\/awz052","volume":"142","author":"JA Pijpers","year":"2019","unstructured":"Pijpers JA, Kies DA, Louter MA, Van Zwet EW, Ferrari MD, Terwindt GM (2019) Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial. Brain 142(5):1203\u20131214","journal-title":"Brain"},{"issue":"9","key":"1982_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1468-2982.2006.01175.x","volume":"26","author":"P Rossi","year":"2006","unstructured":"Rossi P, Lorenzo CD, Faroni J, Cesarino F, Nappi G (2006) Advice Alone Vs. Structured Detoxification Programmes for Medication Overuse Headache: A Prospective, Randomized, Open-Label Trial in Transformed Migraine Patients With Low Medical Needs. Cephalalgia. 26(9):1097\u2013105","journal-title":"Cephalalgia."},{"issue":"1","key":"1982_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1129-2377-14-10","volume":"14","author":"P Rossi","year":"2013","unstructured":"Rossi P, Faroni JV, Tassorelli C, Nappi G (2013) Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. J Headache Pain 14(1):10","journal-title":"J Headache Pain"},{"issue":"4","key":"1982_CR30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10194-011-0339-z","volume":"12","author":"G Sandrini","year":"2011","unstructured":"Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G et al (2011) Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain 12(4):427\u2013433","journal-title":"J Headache Pain"},{"issue":"8","key":"1982_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.euroneuro.2014.03.010","volume":"24","author":"P Sarchielli","year":"2014","unstructured":"Sarchielli P, Messina P, Cupini LM, Tedeschi G, Di Piero V, Livrea P et al (2014) Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial. Eur Neuropsychopharmacol 24(8):1289\u20131297","journal-title":"Eur Neuropsychopharmacol"},{"issue":"7","key":"1982_CR32","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","volume":"27","author":"HC Diener","year":"2007","unstructured":"Diener HC, Bussone G, Oene JV, Lahaye M, Schwalen S, Goadsby P (2007) Topiramate Reduces Headache Days in Chronic Migraine: A Randomized, Double-Blind. Placebo-Controlled Study Cephalalgia 27(7):814\u2013823","journal-title":"Placebo-Controlled Study Cephalalgia"},{"key":"1982_CR33","doi-asserted-by":"crossref","unstructured":"Schwedt TJ, Hentz JG, Sahai-Srivastava S, Murinova N, Spare NM, Treppendahl C, et al. Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial. Neurology. 2022 Apr 5 [cited 2025 Jan 3];98(14). Available from: https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000200117","DOI":"10.1212\/WNL.0000000000200117"},{"issue":"1\u20132","key":"1982_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jns.2013.05.003","volume":"331","author":"SD Silberstein","year":"2013","unstructured":"Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener HC et al (2013) OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. J Neurol Sci 331(1\u20132):48\u201356","journal-title":"J Neurol Sci"},{"issue":"3","key":"1982_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/0333102420966658","volume":"41","author":"DW Dodick","year":"2021","unstructured":"Dodick DW, Doty EG, Aurora SK, Ruff DD, Stauffer VL, Jedynak J et al (2021) Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine. Cephalalgia 41(3):340\u2013352","journal-title":"Cephalalgia"},{"issue":"1","key":"1982_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10072-021-05295-y","volume":"43","author":"A Arab","year":"2022","unstructured":"Arab A, Khoshbin M, Karimi E, Saberian G, Saadatnia M, Khorvash F (2022) Effects of greater occipital nerve block with local anesthetic and triamcinolone for treatment of medication overuse headache: an open-label, parallel, randomized, controlled clinical trial. Neurol Sci 43(1):549\u2013557","journal-title":"Neurol Sci"},{"issue":"2","key":"1982_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/ejp.1500","volume":"24","author":"LS Mose","year":"2020","unstructured":"Mose LS, Pedersen SS, Jensen RH, Gram B (2020) Medication-overuse headache: The effect of a patient educational programme\u2014A randomized controlled trial. Eur J Pain 24(2):435\u2013447","journal-title":"Eur J Pain"},{"issue":"2","key":"1982_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0333102417737779","volume":"38","author":"LN Carlsen","year":"2018","unstructured":"Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L (2018) Complete detoxification is the most effective treatment of medication-overuse headache: A randomized controlled open-label trial. Cephalalgia 38(2):225\u2013236","journal-title":"Cephalalgia"},{"issue":"14","key":"1982_CR39","doi-asserted-by":"publisher","first-page":"1129439","DOI":"10.3389\/fneur.2023.1129439","volume":"3","author":"AV Krymchantowski","year":"2023","unstructured":"Krymchantowski AV, Jevoux C, Krymchantowski AG, Silva-N\u00e9to RP (2023) Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study. Front Neurol 3(14):1129439","journal-title":"Front Neurol"},{"issue":"1","key":"1982_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10539-019-9733-8","volume":"35","author":"P Friesen","year":"2020","unstructured":"Friesen P (2020) Towards an account of the placebo effect: a critical evaluation alongside current evidence. Biol Philos 35(1):11","journal-title":"Biol Philos"},{"issue":"7","key":"1982_CR41","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/ene.14268","volume":"27","author":"HC Diener","year":"2020","unstructured":"Diener HC, Antonaci F, Braschinsky M, Evers S, Jensen R, Lainez M et al (2020) European Academy of Neurology guideline on the management of medication-overuse headache. Eur J Neurol 27(7):1102\u20131116","journal-title":"Eur J Neurol"},{"key":"1982_CR42","doi-asserted-by":"crossref","unstructured":"Tepe N, Tertemi\u0307Z OF. (2021) Comparison of greater occipital nerve and greater occipital nerve + supraorbital nerve block effect in chronic medication overuse headache. Turk J Med Sci. 51(3):1065\u201370","DOI":"10.3906\/sag-2009-101"},{"issue":"6","key":"1982_CR43","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/head.14536","volume":"63","author":"SJ Tepper","year":"2023","unstructured":"Tepper SJ, Lipton RB, Silberstein SD, Kudrow D, Ashina M, Reuter U et al (2023) Long-term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis. Headache J Head Face Pain 63(6):730\u2013742","journal-title":"Headache J Head Face Pain"},{"issue":"11","key":"1982_CR44","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/jamaneurol.2024.3043","volume":"81","author":"SJ Tepper","year":"2024","unstructured":"Tepper SJ, Dodick DW, Lanteri-Minet M, Dolezil D, Gil-Gouveia R, Lucas C et al (2024) Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: A Phase 4, Randomized, Placebo-Controlled Trial. JAMA Neurol 81(11):1140","journal-title":"JAMA Neurol"},{"issue":"1","key":"1982_CR45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12883-023-03477-z","volume":"23","author":"S Yu","year":"2023","unstructured":"Yu S, Zhou J, Luo G, Xiao Z, Ettrup A, Jansson G et al (2023) Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study. BMC Neurol 23(1):441","journal-title":"BMC Neurol"},{"issue":"1","key":"1982_CR46","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s10194-023-01630-0","volume":"24","author":"L Grazzi","year":"2023","unstructured":"Grazzi L, D\u2019Amico D, Guastafierro E, Demichelis G, Erbetta A, Fedeli D et al (2023) Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study). J Headache Pain 24(1):86","journal-title":"J Headache Pain"},{"issue":"10208","key":"1982_CR47","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","volume":"394","author":"L Degenhardt","year":"2019","unstructured":"Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL et al (2019) Global patterns of opioid use and dependence: harms to populations, interventions, and future action. The Lancet 394(10208):1560\u20131579","journal-title":"The Lancet"},{"issue":"5","key":"1982_CR48","doi-asserted-by":"publisher","first-page":"033310242311708","DOI":"10.1177\/03331024231170807","volume":"43","author":"M Ashina","year":"2023","unstructured":"Ashina M, Lanteri-Minet M, Ettrup A, Christoffersen CL, Josiassen MK, Phul R et al (2023) Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study. Cephalalgia 43(5):033310242311708","journal-title":"Cephalalgia"},{"issue":"1","key":"1982_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/head.14036","volume":"61","author":"H Diener","year":"2021","unstructured":"Diener H, Marmura MJ, Tepper SJ, Cowan R, Starling AJ, Diamond ML et al (2021) Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2. Headache J Head Face Pain 61(1):125\u2013136","journal-title":"Headache J Head Face Pain"},{"issue":"1","key":"1982_CR50","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s10194-020-01173-8","volume":"21","author":"SD Silberstein","year":"2020","unstructured":"Silberstein SD, Cohen JM, Seminerio MJ, Yang R, Ashina S, Katsarava Z (2020) The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study. J Headache Pain 21(1):114","journal-title":"J Headache Pain"},{"issue":"2","key":"1982_CR51","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209584","volume":"103","author":"PJ Goadsby","year":"2024","unstructured":"Goadsby PJ, Friedman DI, Holle-Lee D, Demarquay G, Ashina S, Sakai F et al (2024) Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial. Neurology 103(2):e209584","journal-title":"Neurology"},{"issue":"9","key":"1982_CR52","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/head.14206","volume":"61","author":"MJ Marmura","year":"2021","unstructured":"Marmura MJ, Diener H, Cowan RP, Tepper SJ, Diamond ML, Starling AJ et al (2021) Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache. Headache J Head Face Pain 61(9):1421\u20131431","journal-title":"Headache J Head Face Pain"},{"issue":"1","key":"1982_CR53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10194-023-01594-1","volume":"24","author":"C Lampl","year":"2023","unstructured":"Lampl C, MaassenVanDenBrink A, Deligianni CI, Gil-Gouveia R, Jassal T, Sanchez-del-Rio M et al (2023) The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis. J Headache Pain 24(1):56","journal-title":"J Headache Pain"},{"issue":"7","key":"1982_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027953","volume":"9","author":"CP Herd","year":"2019","unstructured":"Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives NJ et al (2019) Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. BMJ Open 9(7):e027953","journal-title":"BMJ Open"},{"key":"1982_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jocn.2019.09.006","volume":"70","author":"X Yuan","year":"2019","unstructured":"Yuan X, Jiang W, Ren X, Liu C, Pan Y, Zou J et al (2019) Predictors of relapse in patients with medication overuse headache in Shanghai: A retrospective study with a 6-month follow-up. J Clin Neurosci 70:33\u201336","journal-title":"J Clin Neurosci"},{"issue":"1","key":"1982_CR56","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12883-015-0422-1","volume":"15","author":"Z Yan","year":"2015","unstructured":"Yan Z, Chen Y, Chen C, Li C, Diao X (2015) Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in China. BMC Neurol 15(1):168","journal-title":"BMC Neurol"},{"issue":"1","key":"1982_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1468-2982.2004.00789.x","volume":"25","author":"Z Katsarava","year":"2005","unstructured":"Katsarava Z, Muessig M, Dzagnidze A, Fritsche G, Diener H, Limmroth V (2005) Medication Overuse Headache: Rates and Predictors for Relapse in a 4-year Prospective Study. Cephalalgia 25(1):12\u201315","journal-title":"Cephalalgia"}],"updated-by":[{"DOI":"10.1186\/s10194-025-02031-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000}}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-01982-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-01982-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-01982-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T15:02:06Z","timestamp":1744815726000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-01982-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1982"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-01982-9","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s10194-025-02031-1","URL":"https:\/\/doi.org\/10.1186\/s10194-025-02031-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PK, SY, SS, TT, and PC declare that there are no conflicts of interest. BRW is the founder of Ceftronics limited and the CEFREF migraine mobile application. He has done consultancy for Invex Therapeutics and received honoraria from AbbVie.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}